Nature Search

Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial

Yago Nieto
Pinaki Banerjee
Katayoun Rezvani
Amendments and Corrections26 Jun 2025
Nature Medicine

Volume: 31, P: 2816
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial

In this phase 1 trial, patients with heavily pretreated and refractory CD30⁺ lymphoma were safely treated with donor-cord-blood-derived NK cells that were precomplexed with the anti-CD30 and anti-CD16A bispecific antibody AFM13, showing encouraging preliminary clinical response rates.

Yago Nieto
Pinaki Banerjee
Katayoun Rezvani
Research04 Apr 2025
Nature Medicine

Volume: 31, P: 1987-1993
Plasma Immunoreactive Pancreatic Cationic Trypsinogen in Cystic Fibrosis: a Sensitive Indicator of Exocrine Pancreatic Dysfunction

Peter R Durie
Corey Largman
Michael C Geokas
Research01 Oct 1981
Pediatric Research

Volume: 15, P: 1351-1355
Age-Related Alterations of Immunoreactive Pancreatic Cationic Trypsinogen in Sera from Cystic Fibrosis Patients with and without Pancreatic Insufficiency

P R Durie
G G Forstner
M L Corey
Research01 Mar 1986
Pediatric Research

Volume: 20, P: 209-213
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma

Oren Pasvolsky
Curtis Marcoux
Muzaffar H. Qazilbash
Research05 Dec 2025
Bone Marrow Transplantation

P: 1-9
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients

Oren Pasvolsky
Denái R. Milton
Muzaffar H. Qazilbash
ResearchOpen Access03 May 2023
Blood Cancer Journal

Volume: 13, P: 1-7
Author Correction: The immunoregulatory landscape of human tuberculosis granulomas

Erin F. McCaffrey
Michele Donato
Michael Angelo
Amendments and CorrectionsOpen Access11 Mar 2022
Nature Immunology

Volume: 23, P: 814
The immunoregulatory landscape of human tuberculosis granulomas

MIBI-TOF is a mass spectrometry-based multiplexed imaging platform that has been used to map tumors. In this Resource article, MIBI-TOF is used to provide a spatial atlas of immune responses within human tuberculosis granulomas.

Erin F. McCaffrey
Michele Donato
Michael Angelo
ResearchOpen Access20 Jan 2022
Nature Immunology

Volume: 23, P: 318-329
Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis

Jeremy Ramdial
Partow Kebriaei
Rohtesh S. Mehta
Research02 May 2024
Leukemia

Volume: 38, P: 1432-1434
Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy

J. Ramdial
K. H. Chan
Y. Nieto
Research25 Mar 2023
Bone Marrow Transplantation

Volume: 58, P: 635-638
Romidepsin antagonism with CHOEP

J. L. Ramdial
B. C. Valdez
Y. Nieto
Research11 Mar 2023
Leukemia

Volume: 37, P: 1160-1161
Optimal infused CD34⁺ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation

Oren Pasvolsky
Curtis Marcoux
Muzaffar H. Qazilbash
ResearchOpen Access31 Oct 2024
Blood Cancer Journal

Volume: 14, P: 1-8
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas

Jeremy Ramdial
Ruitao Lin
Yago Nieto
ResearchOpen Access28 Sept 2024
Bone Marrow Transplantation

Volume: 59, P: 1754-1762
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation

Oren Pasvolsky
Zhongya Wang
Muzaffar H. Qazilbash
ResearchOpen Access17 May 2024
Blood Cancer Journal

Volume: 14, P: 1-7
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience

Oren Pasvolsky
Sassine Ghanem
Muzaffar H. Qazilbash
ResearchOpen Access10 Jan 2024
Blood Cancer Journal

Volume: 14, P: 1-8
KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma

Mahmoud R. Gaballa
Junsheng Ma
Muzaffar H. Qazilbash
Research06 May 2022
Bone Marrow Transplantation

Volume: 57, P: 1142-1149
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis

Alexandre E. Malek
Taha Al-Juhaishi
Sairah Ahmed
Correspondence14 Feb 2024
Bone Marrow Transplantation

Volume: 59, P: 699-704
Hematopoietic cell transplantation can be safely performed after COVID-19

Alejandro Marinos
Jeremy Ramdial
Roy F. Chemaly
Correspondence19 Sept 2023
Bone Marrow Transplantation

Volume: 58, P: 1410-1412
Can we cure refractory Hodgkin’s lymphoma with transplantation?

Stefan O. Ciurea
Piyanuch Kongtim
Anca Colita
Correspondence07 Jul 2020
Bone Marrow Transplantation

Volume: 56, P: 278-281

Search

Filter By:

Search

Quick links